Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Active, not recruiting	Phase 2	2026-09-11		NCT01585805

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chaim Sheba Medical Center	Tel Litwinsky	Israel	9
Ingalls Memorial Hospital	Harvey	United States	100
Memorial Sloan Kettering Basking Ridge	Basking Ridge	United States	189
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Memorial Sloan Kettering Commack	Commack	United States	189
Memorial Sloan Kettering Nassau	Uniondale	United States	193
Memorial Sloan Kettering Westchester	Harrison	United States	204
Mercy Hospital Saint Louis	St Louis	United States	293
Shaare Zedek Medical Center	Jerusalem	Israel	22
University Health Network-Princess Margaret Hospital	Toronto	Canada	88
University of Chicago Comprehensive Cancer Center	Chicago	United States	273
University of Michigan Rogel Cancer Center	Ann Arbor	United States	186